Latest Stories

P
Why It Moves

Planet Labs (PL) Shares Skyrocket, What You Need To Know

Shares of earth imaging satellite company Planet Labs (NYSE:PL) jumped 36.6% in the afternoon session after it reported much better-than-expected financial results for its third quarter and provided a strong outlook. 

Dec 11, 2025
L
Why It Moves

Eli Lilly (LLY) Stock Is Up, What You Need To Know

Shares of global pharmaceutical company Eli Lilly (NYSE:LLY) jumped 3.4% in the morning session after the company announced highly positive Phase 3 trial results for its next-generation weight loss candidate, retatrutide. 

Dec 11, 2025
H
Why It Moves

Why Robinhood (HOOD) Shares Are Getting Obliterated Today

Shares of financial services company Robinhood (NASDAQ:HOOD) fell 9.1% in the morning session after the company reported weak operating data for November 2025, showing declines in funded customers and trading volumes. 

Dec 11, 2025
D
Why It Moves

Why DigitalOcean (DOCN) Shares Are Falling Today

Shares of cloud computing platform DigitalOcean (NYSE:DOCN) fell 4.8% in the morning session after a broader sell-off in technology stocks dragged down the shares as bellwether Oracle's disappointing earnings report sparked fears about heavy spending on artificial intelligence (AI). 

Dec 11, 2025
C
Why It Moves

Why Coherent (COHR) Stock Is Down Today

Shares of materials and photonics company Coherent (NYSE:COHR) fell in the morning session after major investor Bain Capital offered to sell another significant block of the company's shares at a potential discount. According to reports, Goldman Sachs offered 5 million of Bain Capital's shares in a price range that represented a potential discount of up to 3.4% from the previous day's closing price. The offering, valued at up to $987.3 million, marked the third time in just over a month that the private equity firm moved to reduce its holdings in the laser equipment maker. Such a large sale, particularly at a reduced price, often puts downward pressure on a stock's price as it increases the supply of shares available on the market and can signal a decreased confidence from a major shareholder.

Dec 11, 2025
O
Why It Moves

Oscar Health (OSCR) Stock Is Up, What You Need To Know

Shares of health insurance company Oscar Health (NYSE:OSCR) jumped 4% in the morning session after Stephens & Co. initiated coverage on the stock with an "Equal-Weight" rating and a $17 price target. 

Dec 11, 2025
D
Why It Moves

Why Designer Brands (DBI) Shares Are Trading Lower Today

Shares of footwear and accessories discount retailer Designer Brands (NYSE:DBI) fell 6.3% in the morning session after the stock pulled back as the company reported mixed third-quarter results, with an earnings beat overshadowed by a sales miss and declining comparable sales. 

Dec 11, 2025
A
Why It Moves

Why Allstate (ALL) Stock Is Up Today

Shares of insurance giant Allstate (NYSE:ALL) jumped 2.9% in the morning session after Wolfe Research maintained its "Outperform" rating on the stock, contributing to the positive move. The investment firm did, however, slightly lower its price target on Allstate to $244 from $250. The stock's rise suggested investors focused more on the continued positive rating than the minor target adjustment. The move also came as the wider stock market broke a three-day losing streak. This broader market rebound, reportedly helped by a rate cut from the U.S. Federal Reserve, likely provided an additional lift for Allstate's shares.

Dec 11, 2025
T
Why It Moves

Why 10x Genomics (TXG) Stock Is Nosediving

Shares of biotech company 10x Genomics (NASDAQ:TXG) fell 6.3% in the morning session after Citigroup downgraded the stock to Neutral from Buy. 

Dec 11, 2025
C
Why It Moves

Centene (CNC) Stock Trades Up, Here Is Why

Shares of health coverage company Centene (NYSE:CNC) jumped 5.8% in the morning session after Baird raised its price target on the stock to $36 from $28, though the firm maintained its Neutral rating. The move from the investment firm suggested an improved outlook on the company's valuation, even as it stopped short of a full recommendation to buy the shares. Adding to the positive sentiment, the Hotchkis & Wiley Mid-Cap Value Fund noted in a recent investor letter that it viewed Centene as an attractive investment. The fund pointed to the company's position as a clear market leader where scale provides a significant competitive edge.

Dec 11, 2025